372 related articles for article (PubMed ID: 24503126)
1. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
[TBL] [Abstract][Full Text] [Related]
2. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.
Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D
ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836
[TBL] [Abstract][Full Text] [Related]
4. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
Xiao B; Ma P; Viennois E; Merlin D
Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
6. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
[TBL] [Abstract][Full Text] [Related]
7. Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
Laroui H; Geem D; Xiao B; Viennois E; Rakhya P; Denning T; Merlin D
Mol Ther; 2014 Jan; 22(1):69-80. PubMed ID: 24025751
[TBL] [Abstract][Full Text] [Related]
8. The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.
Krause P; Zahner SP; Kim G; Shaikh RB; Steinberg MW; Kronenberg M
Gastroenterology; 2014 Jun; 146(7):1752-62.e4. PubMed ID: 24560868
[TBL] [Abstract][Full Text] [Related]
9. Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation.
Kucharzik T; Lugering A; Yan Y; Driss A; Charrier L; Sitaraman S; Merlin D
Lab Invest; 2005 Jul; 85(7):932-41. PubMed ID: 15880135
[TBL] [Abstract][Full Text] [Related]
10. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
[TBL] [Abstract][Full Text] [Related]
11. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
[TBL] [Abstract][Full Text] [Related]
13. Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.
Sharma D; Malik A; Guy CS; Karki R; Vogel P; Kanneganti TD
Gastroenterology; 2018 Mar; 154(4):948-964.e8. PubMed ID: 29203393
[TBL] [Abstract][Full Text] [Related]
14. Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis.
Bao WL; Wu Q; Hu B; Sun D; Zhao S; Shen X; Cheng H; Shen W
Int J Nanomedicine; 2021; 16():345-357. PubMed ID: 33488076
[TBL] [Abstract][Full Text] [Related]
15. TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow.
Judd LM; Chalinor HV; Walduck A; Pavlic DI; Däbritz J; Dubeykovskaya Z; Wang TC; Menheniott TR; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(1):G12-24. PubMed ID: 25324506
[TBL] [Abstract][Full Text] [Related]
16. Role of metallothioneins as danger signals in the pathogenesis of colitis.
Devisscher L; Hindryckx P; Lynes MA; Waeytens A; Cuvelier C; De Vos F; Vanhove C; Vos MD; Laukens D
J Pathol; 2014 May; 233(1):89-100. PubMed ID: 24452846
[TBL] [Abstract][Full Text] [Related]
17. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
Zhang M; Wang X; Han MK; Collins JF; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1927-1943. PubMed ID: 28665164
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.
Schoellhammer CM; Lauwers GY; Goettel JA; Oberli MA; Cleveland C; Park JY; Minahan D; Chen Y; Anderson DG; Jaklenec A; Snapper SB; Langer R; Traverso G
Gastroenterology; 2017 Apr; 152(5):1151-1160. PubMed ID: 28088460
[TBL] [Abstract][Full Text] [Related]
20. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
